OKRA Technologies
We use AI-powered analytics to save and improve human lives, driving health and market outcomes where they matter most.
OKRA Technologies
We use AI-powered analytics to save and improve human lives, driving health and market outcomes where they matter most.
TL;DR
Founded: 2015
Headquarters: Cambridge, UK; additional hub in Leiden, Netherlands
Core product: OKRA.ai Brain — AI platform for life sciences commercial, medical, access/pricing and RWE insights
Exit: Acquired by Envision Pharma Group (Feb 7, 2023)
Company Overview
Problem Domain
Converting fragmented clinical, scientific and commercial data into decision-ready insights for pharmaceutical and life-sciences organisations.
Founded
2015
Industry
Life sciences / Pharmaceutical AI
Funding Track Record
Crunchbase lists a Seed round with Jim Cockburn identified as lead investor.
$4.16M
Dealroom lists a Series A in March 2018 and names investors including Pentium Capital Partners and Carter Brown.
OKRA.ai was acquired by Envision Pharma Group (announcement dated Feb 7, 2023).
Investor Signal
“Reported investors include Pentium Capital Partners, Carter Brown; Crunchbase lists Jim Cockburn (seed).”